Medicine Description kansartan-plus 300 / 12.5 mg
kansartan plus 300 / 12.5 mg tablets is a medication that combines hydrochlorothiazide and irbesartan to effectively manage hypertension. Hydrochlorothiazide functions as a thiazide diuretic, promoting renal excretion of sodium and water, which reduces blood volume and, consequently, blood pressure. Irbesartan, an angiotensin II receptor blocker (ARB), prevents angiotensin II from binding to its receptors, leading to vasodilation (the widening of blood vessels) and reduced secretion of aldosterone. This dual mechanism not only helps in lowering blood pressure but also provides protective effects on the kidneys, particularly in diabetic patients, by reducing proteinuria and renal damage.
Indications and Uses of kansartan plus 300 / 12.5 mg tablets
- Management of essential hypertension
- Reduction of cardiovascular risk in patients with existing heart disease
- Prevention of renal complications in patients with type 2 diabetes and hypertension
- Adjunct therapy for patients with high levels of protein and creatinine in the blood
Side Effects of kansartan plus 300 / 12.5 mg tablets
- Dizziness or lightheadedness
- Fatigue
- Headache
- Increased urination
- Electrolyte imbalances, such as low potassium levels
Storage and Handling
Store kansartan plus tablets at room temperature, away from moisture and heat. Ensure the medication is kept out of reach of children and pets.
Patient Advice and Precautions
Patients should be advised to monitor their blood pressure regularly and report any significant changes to their healthcare provider. Maintaining a balanced diet and staying hydrated is also important, as is the need to inform healthcare professionals about any other medications being taken to avoid potential interactions. Regular follow-up appointments are essential to evaluate the effectiveness of the treatment and make any necessary adjustments.